The Chemours Company(CC)Earnings, Financials & Key RatiosThe Chemours Company (CC) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2026Q1
the company's precarious financial health is underscored by a debt-to-equity ratio of 20.33 and a history of volatile free cash flow, including a $693 million deficit in 2024Q2.
The Chemours Company (CC) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
The Chemours Company (CC) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 5, 2026 | $0.05vs $0.05+200.0% | $1.4Bvs $1.4B-1.3% |
| Q1 2026 | Feb 19, 2026 | $0.05vs $0.09-43.6% | $1.3Bvs $1.3B+0.0% |
| Q4 2025 | Nov 6, 2025 | $0.20vs $0.24-16.7% | $1.5Bvs $1.3B+12.5% |
| Q3 2025 | Aug 5, 2025 | $0.58vs $0.46+26.1% | $1.6Bvs $1.5B+4.7% |
Recent stock market news and headlines for The Chemours Company (CC)
Stockholm, July 1st, 2026 – Virtune today announces the completion of the rebalancing for the Virtune Stablecoin Index ETP (SE0026821282), listed on Nasdaq Stockholm, Nasdaq Helsinki and Xetra.
Chemours (CC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Chemours Reaches Agreement with U.S. EPA to Resolve Claims Relating to PFAS PR Newswire WILMINGTON, Del., June 2
The settlement resolves the federal government's claims relating to discharge of PFAS compounds across three current operating sites, as well as certain environmental claims by the State of West Virginia. Chemours is expected to pay EPA and WVDEP a $22.5 million civil penalty over a three-year period, and fund $90 million in additional mitigation projects over the next 15 years to further reduce PFAS emissions and enhance certain existing off-site drinking water programs.
NEW YORK, June 18, 2026 /PRNewswire/ -- Canton Strategic Holdings, Inc. (NASDAQ: CNTN) ("Canton Strategic Holdings" or the "Company"), the first publicly traded company to leverage Canton Coin (CC) to support the Canton Network's ability to digitize traditional financial markets, today announced it is expected to join the broad-market Russell 3000® Index and the small-cap Russell 2000® Index following the semi-annual reconstitution, effective after market close on June 26, 2026, according to a preliminary list of additions published by FTSE Russell. "As the only company providing active equity exposure to the Canton Network ecosystem, we are proud to be considered for inclusion in the Russell 3000® and Russell 2000®, including their respective value and growth indices," said Mark Wendland, Chairman and Chief Executive Officer of Canton Strategic Holdings.
Key metrics vs top competitors for The Chemours Company (CC)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $18.19 | $2.73B | -7.11 | 0.45% | -6.65% | -90.19% | 2.85% | |
| $6.03 | $961.86M | -2.03 | -5.73% | -12.3% | -30.42% | — | |
| $5.84 | $671.91M | -6.08 | -1.47% | -7.12% | -17% | — | |
| $19.75 | $2.25B | -53.38 | 3.68% | -1.89% | -6.64% | — | |
| $20.10 | $541.88M | 11.17 | 0.31% | 0.67% | 1.28% | — | |
| $10.58 | $1.84B | -6.65 | -5.85% | -5.69% | -8.14% | — |
The Chemours Company (CC) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
The Chemours Company (CC) SEC filings — annual & quarterly reports (10-K, 10-Q)
May 5, 2026·SEC
Apr 30, 2026·SEC
Mar 12, 2026·SEC
Get notified when CC posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
The Chemours Company (CC) stock FAQ — growth, dividends, profitability & financials explained
The Chemours Company (CC) reported $5.82B in revenue for fiscal year 2025. This represents a 21% decrease from $7.37B in 2012.
The Chemours Company (CC) grew revenue by 0.4% over the past year. Growth has been modest.
The Chemours Company (CC) reported a net loss of $411.0M for fiscal year 2025.
Yes, The Chemours Company (CC) pays a dividend with a yield of 2.85%. This makes it attractive for income-focused investors.
The Chemours Company (CC) has a return on equity (ROE) of -90.2%. Negative ROE indicates the company is unprofitable.
The Chemours Company (CC) generated $198.0M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
